DIMACS Working Group on Adverse Event/Disease Reporting, Surveillance, and Analysis I
DIMACS Subgroup on Adverse Event/Disease Reporting, Surveillance, and Analysis
DIMACS Working Group on Adverse Event/Disease Reporting, Surveillance, and Analysis II
Participants in the Working Group on Adverse Event/Disease Reporting, Surveillance, and Analysis IV
|
|
---|---|
Robert Ball | FDA |
Warren Bilker | University of Pennsylvania |
John Clarke | Gault Associates |
Bill DuMouchel | Lincoln Technologies |
Susan Ellenberg | University of Pennsylvania |
Aimin Feng | Rutgers Unviersity |
Victor Gogolak | Drug Logic |
David Goldsmith | Emory University |
Manfred Hauben | Pfizer |
Guillermo Herrera | CDC |
Martin Kulldorff | Harvard University |
David Madigan | Rutgers University |
Lester Reich | Pfizer |
Henry Rolka | CDC |
Galit Shmueli | University of Maryland |
Ivan Zorych | DIMACS |